JUPITER-02 Findings Poised to Change Treatment Paradigm for Nasopharyngeal Carcinoma

The addition of the immunotherapy agent toripalimab (Coherus/Junshi Biosciences) to standard first-line ...

NOVEMBER 22, 2021